ANO1 and cancer: More recently, ANO1-mediated PI3K-AKT activation has been shown to impair ferroptosis in gastrointestinal cancers while simultaneously remodeling the tumor microenvironment through recruitment of cancer-associated fibroblasts (CAFs) and suppression of CD8+ T-cell activity [220].